AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 16412747
Drug: Topical estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical estrogen therapy
Trial: 9690480
Drug: Placebo following
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo following a 1-week LMWH treatment (once daily)
Trial: 3319640
Drug: Nicardipine 30
RxNorm normalized name: niCARdipine 30 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine 30 mg t.d.s.
Trial: 3319640
Drug: Propranolol 80
RxNorm normalized name: propranolol 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 80 mg t.d.s.
Trial: 27403851
Drug: l-Tyrosine (TYR)
DrugBank: Tyrosine (DB00135)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: l-Tyrosine (TYR) supplementation
Trial: 24604243
Drug: Almorexant 100
RxNorm normalized name: Nemorexant
DrugBank: Daridorexant (DB15031)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Almorexant 100 mg
Trial: 26734954
Drug: Red wine
RxNorm normalized name: Red wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red wine (230 ml/day for women, 300 ml/day for men)
Trial: 22848584
Drug: Psyllium supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psyllium supplementation (6 g/day for 6 weeks)
Trial: 16045013
Drug: Simvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (20 mg/d) + Benazepril (10 mg/d)
Trial: 8841148
Drug: Quinidine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine (200 mg)
Trial: 7480098
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of nifedipine (20 mg) and quinidine (200 mg)
Trial: 2110817
Drug: Non-sedative antihistamine
RxNorm normalized name: Ahist Antihistamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-sedative antihistamine terfenadine (60 mg b.i.d.)
Trial: 2110817
Drug: Sedative antihistamine
RxNorm normalized name: Ahist Antihistamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sedative antihistamine clemastine (2 mg b.i.d.)
Trial: 29349922
Drug: Breast milk
RxNorm normalized name: BREAST MILK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breast milk intake at 9-10 months of age (mean 752 g/day)
Trial: 27225338
Drug: 60 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg/kg magnesium sulfate via cardioplegic solution
Trial: 27225338
Drug: 100 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/kg magnesium sulfate via cardioplegic solution
Trial: 27225338
Drug: 80 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg/kg and 100 mg/kg magnesium sulfate
Trial: 20403667
Drug: Late enteral
RxNorm normalized name: Soy protein isolate enteral formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late enteral nutrition (LEN) group, received only intravenous resuscitation in the first 48 hours
Trial: 30048979
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no metformin)
Trial: 7519032
Drug: 1,24(OH)2D3 ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,24(OH)2D3 ointment (tacalcitol; 4 micrograms/g)
Trial: 2928741
Drug: Clonidine 0.075
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 0.075 mg twice daily
Trial: 1410124
Drug: Alcohol (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (high dose: 1.1 ml. ethanol/kilogram body weight)
Trial: 648938
Drug: Cimetidine treatment
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine treatment for 12 weeks
Trial: 26319612
Drug: biofortified gari
RxNorm normalized name: thiamine
DrugBank: Thiamine (DB00152)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: biofortified gari (1 mg β‐carotene)
Trial: 26319612
Drug: unfortified gari
RxNorm normalized name: thiamine
DrugBank: Thiamine (DB00152)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: unfortified gari (0.3 mg retinyl palmitate reference dose)
Trial: 20644943
Drug: Clopidogrel 75
RxNorm normalized name: clopidogrel 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 75 mg q.d.
Trial: 20644943
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 100 mg q.d.
Trial: 16458133
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ASA and clopidogrel
Trial: 17589944
Drug: Chemoradiation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoradiation therapy (gemcitabine and radiation dose 50.4 Gy) before surgery
Trial: 15140780
Drug: PVAC (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PVAC (50 micro g)
Trial: 2675439
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg chlorophyll tablets thrice daily
Trial: 1089971
Drug: Synthetic luteinizing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic luteinizing hormone-releasing hormone (LH-RH) 50 μg
Trial: 1089971
Drug: Synthetic luteinizing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic luteinizing hormone-releasing hormone (LH-RH) 100 μg
Trial: 1089971
Drug: Two injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two injections of LH-RH 90 min apart
Trial: 1089971
Drug: Two injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two injections of LH-RH 30 or 45 min apart
Trial: 1089971
Drug: Lower doses
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower doses of LH-RH (not specified)
Trial: 20579847
Drug: Fructo-oligosaccharides (FOS)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fructo-oligosaccharides (FOS) 10 g/d
Trial: 19279365
Drug: CDC model
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDC model early stimulation therapy (home-based)
Trial: 15033892
Drug: Fentanyl 5
RxNorm normalized name: fentanyl 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 5 microg ml(‐1) in bupivacaine 0.1%
Trial: 15033892
Drug: Fentanyl 10
RxNorm normalized name: FENTANYL 100MCG/HR PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 10 microg ml(‐1) in bupivacaine 0.1%
Trial: 14597359
Drug: External beam
RxNorm normalized name: Beam
DrugBank: Tricyclazole (DB02891)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: External beam radiation therapy
Trial: 9587125
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy for metastatic disease
Trial: 9587125
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with doxorubicin-containing regimens
Trial: 7725890
Drug: Diclofenac 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 1.0 mg.kg‐1 i.v. after general anaesthesia induction, before surgical incision, and four hours later the same dose was given i.m.
Trial: 7725890
Drug: Ketoprofen 1.35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen 1.35 mg.kg‐1 i.v. and i.m.
Trial: 7028759
Drug: Multi-drug chemotherapy
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-drug chemotherapy with local radiotherapy (5-FU and local radiotherapy to a dose of 4600 rad, then Methyl-CCNU)
Trial: 7028759
Drug: Multi-drug chemotherapy
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-drug chemotherapy without radiotherapy (5-FU and Methyl-CCNU)
Trial: 7028759
Drug: Multi-drug chemotherapy
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-drug chemotherapy with local radiotherapy
Trial: 7028759
Drug: Multi-drug chemotherapy
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-drug chemotherapy without radiotherapy
Trial: 29127417
Drug: Xueshuan Xinmai
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xueshuan Xinmai tablets (XXMT)
Trial: 18394772
Drug: Nifedipine gastrointestinal
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine gastrointestinal therapeutic system (GITS) tablets (90 mg/d)
Trial: 15744147
Drug: Non-viral IL-2
RxNorm normalized name: IL-3 (NON-GLYCOSYLATED)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-viral IL-2 gene therapy
Trial: 15744147
Drug: Control plasmid
RxNorm normalized name: plasmin
DrugBank: Fibrinolysin (DB05254)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control plasmid in cationic lipid formulation
Trial: 15744147
Drug: Methotrexate chemotherapy
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate chemotherapy
Trial: 10568212
Drug: DHEP gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEP gel
Trial: 9082374
Drug: Captopril (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (50 mg/d)
Trial: 8453465
Drug: Oral response
RxNorm normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Oral response mode
Trial: 27681572
Drug: TAU plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAU plus four 2.5-h weekly sessions of theory-based lifestyle structured group education, maintenance contact every 2 weeks, and 'booster' sessions every 3 months.
Trial: 17445284
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g low molecular weight (LMW) BBG
Trial: 17445284
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g high molecular weight (HMW) BBG
Trial: 17445284
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g low molecular weight (LMW) BBG
Trial: 17445284
Drug: TAG (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAG (all treatment groups)
Trial: 1885426
Drug: Acyclovir 400
RxNorm normalized name: acyclovir 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir 400 mg twice daily for five days
Trial: 1885426
Drug: Acyclovir 200
RxNorm normalized name: acyclovir 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir 200 mg twice a day for five days
Trial: 21681516
Drug: Dienogest (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dienogest (2 mg once daily, orally)
Trial: 19349517
Drug: Nikkomycin Z
RxNorm normalized name: Nikkomycin Z
DrugBank: Nikkomycin Z (DB12939)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nikkomycin Z (all doses)
Trial: 17484872
Drug: severe recurrence
RxNorm normalized name: acetaminophen / diphenhydramine hydrochloride Oral Tablet [Tylenol Severe Allergy]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: severe recurrence treatment (group C)
Trial: 17484872
Drug: treatment (overall)
RxNorm normalized name: Hongo Killer Treatment
DrugBank: Pyrithione (DB06815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: treatment (overall)
Trial: 11782895
Drug: Micronized diosmin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized diosmin (Daflon 500 mg)
Trial: 2065410
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no patch)
Trial: 7073303
Drug: Single-dose trimethoprim-sulphamethoxazole
RxNorm normalized name: sulfamethoxazole / trimethoprim
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose trimethoprim-sulphamethoxazole
Trial: 31036580
Drug: Ace‐ER 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ace‐ER 6 g/d
Trial: 28527855
Drug: XR-NTX treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: XR-NTX treatment prior to release
Trial: 28527855
Drug: Post-release XR-NTX
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-release XR-NTX treatment
Trial: 26044070
Drug: bapineuzumab 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bapineuzumab 0.15 mg/kg
Trial: 18985345
Drug: d-amphetamine (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-amphetamine (0.3 mg/kg i.v.)
Trial: 15682684
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen (HBO2) treatment (2.8 atmospheres absolute, 100 minutes, three treatments within the first 24 hours)
Trial: 8080233
Drug: Mebendazole 500
RxNorm normalized name: mebendazole 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mebendazole 500 mg single dose
Trial: 2439814
Drug: atenolol 100
RxNorm normalized name: atenolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atenolol 100 mg
Trial: 18391051
Drug: Group cognitive-behavioral
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group cognitive-behavioral treatment (CBT)
Trial: 30203758
Drug: Lamivudine in
RxNorm normalized name: Product containing lamivudine in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamivudine in addition to conventional Anti-TB therapy and liver-protecting therapy
Trial: 30203758
Drug: Conventional Anti-TB
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Anti-TB therapy and liver-protecting therapy
Trial: 24809770
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (nasal saline irrigation + INS)
Trial: 12145999
Drug: Exemestane 25
RxNorm normalized name: exemestane 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exemestane 25 mg
Trial: 12145999
Drug: Exemestane 50
RxNorm normalized name: Exemestane
DrugBank: Exemestane (DB00990)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exemestane 50 mg
Trial: 12145999
Drug: Exemestane 25
RxNorm normalized name: exemestane 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exemestane 25 mg (crossover study)
Trial: 8679024
Drug: Group II:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group II: 50 mg of 0.25% bupivacaine and 100 micrograms of fentanyl
Trial: 30677646
Drug: Incongruent medications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incongruent medications
Trial: 25070148
Drug: FDC of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FDC of Soli 6 mg plus TOCAS 0.4 mg or Soli 9 mg plus TOCAS 0.4 mg
Trial: 20399146
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of imipramine with pseudoephedrine
Trial: 9882084
Drug: Dexketoprofen 25
RxNorm normalized name: dexketoprofen 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexketoprofen 25 mg
Trial: 23360885
Drug: Dexketoprofen 50
RxNorm normalized name: dexketoprofen
DrugBank: Dexketoprofen (DB09214)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexketoprofen 50 mg
Trial: 8255126
Drug: Dipyrone 2
RxNorm normalized name: dipyrone 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyrone 2 g
Trial: 7633015
Drug: Clinafloxacin 200
RxNorm normalized name: Finafloxacin
DrugBank: Finafloxacin (DB09047)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clinafloxacin 200 mg iv q12h
Trial: 7633015
Drug: Theophylline 300
RxNorm normalized name: theophylline 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline 300 mg tid (initially) then reduced to 200 mg tid after toxicity was observed
Trial: 2199211
Drug: Chlorbutol (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorbutol (2.5 mg.ml-1)
Trial: 2199211
Drug: Methacholine (0.13-4.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methacholine (0.13-4.0 mg.ml-1)
Trial: 31034594
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy (OT) and physical therapy (PT)
Trial: 28383379
Drug: pH‐balanced vaginal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pH‐balanced vaginal gel containing lactic acid
Trial: 28383379
Drug: Placebo (lactate‐free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (lactate‐free gel)
Trial: 19559137
Drug: Daily use
RxNorm normalized name: ALCOHOL 75 mL in 100 mL TOPICAL GEL [Better For Daily Use EAAE Disinfectant]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily use of peppermint oil
Trial: 11501507
Drug: Calcitriol 3
RxNorm normalized name: CALCITRIOL 3MCG/GM OINT,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcitriol 3 microg g(-1) ointment (Silkis ointment)
Trial: 9375952
Drug: Metoprolol CR/XL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol CR/XL (12.5 mg or 25 mg once daily, titrated to 200 mg)
Trial: 18954355
Drug: 1.23% sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.23% sodium fluoride gel administered topically every 24 h for 6 consecutive days
Trial: 16176154
Drug: CoQ10 Q-Gel
RxNorm normalized name: Q-Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CoQ10 Q-Gel Softsules
Trial: 30185793
Drug: CBD 16
RxNorm normalized name: CBD
DrugBank: Cannabidiol (DB09061)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: CBD 16 mg
Trial: 18945240
Drug: Oral oxycodone
RxNorm normalized name: oxycodone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral oxycodone 0.125 mg/kg
Trial: 15823446
Drug: Lyso-PAF (L-PAF)
RxNorm normalized name: pafuramidine
DrugBank: Pafuramidine (DB06532)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lyso-PAF (L-PAF) challenge
Trial: 1740930
Drug: Unlimited intravenous
RxNorm normalized name: MENTHOL 125 mg in 1 mL TOPICAL CREAM [CBD UNLIMITED BALM TOPICAL ANALGESIC]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unlimited intravenous fluids (1294 +/- 58 ml)
Trial: 1740930
Drug: Fluid restriction
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluid restriction (500 ml or less, 485 +/- 2 ml)
Trial: 6408663
Drug: 150 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg/day amitriptyline (AT)
Trial: 29992370
Drug: 1.2 mg
RxNorm normalized name: RNA 1.2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 mg beloranib
Trial: 28556449
Drug: 1.8 mg
RxNorm normalized name: menthol 1.8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.8 mg beloranib
Trial: 25393812
Drug: Independent daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Independent daily stress
Trial: 25393812
Drug: Dependent daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dependent daily stress
Trial: 23290219
Drug: Negative pressure
RxNorm normalized name: DRESSING,NEGATIVE PRESSURE WOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative pressure wound therapy (NPWT) + basic fibroblast growth factor (bFGF)
Trial: 1443508
Drug: Racemic ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Racemic ketamine (2 mg/kg)
Trial: 1443508
Drug: S(+)‐ketamine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S(+)‐ketamine (1 mg/kg)
Trial: 3513810
Drug: Slow-release tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow-release tablets (5 mg terbutaline sulphate, every 12 h)
Trial: 25651782
Drug: Tofacitinib 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tofacitinib 15 mg BID
Trial: 15886669
Drug: SIS wound
RxNorm normalized name: Oasis Wound Matrix, 3X7cm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SIS wound matrix plus compression therapy (n = 62)
Trial: 15886669
Drug: Compression therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compression therapy alone (n = 58)
Trial: 19132881
Drug: Nortriptyline and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nortriptyline and Sertraline
Trial: 16137089
Drug: Directly loaded
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Directly loaded Brånemark System or Replace Select Tapered implants (Nobel Biocare AB)
Trial: 8538189
Drug: Difluoromethylornithine (DFMO)
RxNorm normalized name: α-difluoromethylornithine
DrugBank: Eflornithine (DB06243)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Difluoromethylornithine (DFMO) at a dose of 0.25 gm/m2 per day
Trial: 7011113
Drug: Reproterol (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reproterol (20 mg)
Trial: 7011113
Drug: Reproterol (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reproterol (30 mg)
Trial: 1415392
Drug: Terbutaline (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline (5 mg)
Trial: 30253043
Drug: Obeticholic acid
RxNorm normalized name: Obeticholic acid
DrugBank: Obeticholic acid (DB05990)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Obeticholic acid (OCA) 25 mg once daily for 72 weeks
Trial: 27137142
Drug: Indomethacin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (50 mg every 8 hours)
Trial: 15322526
Drug: Anti-amyloid strategies
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-amyloid strategies (including secretase inhibition, amyloid-beta aggregation inhibition, immunotherapy)
Trial: 11253857
Drug: Prophylactic drug
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic drug therapy
Trial: 11253857
Drug: Prophylaxis administered
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylaxis administered selectively to high-risk patients
Trial: 9141112
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg budesonide b.i.d. from Aiolos nebulizer